Akebia Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Akebia Therapeutics

Access the complete profile.

Akebia Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	62134 Physical, Occupational & Speech Therapists & Audiologists
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	245 1st St Ste 1400 Cambridge, MA 02142

Note: Revenues for privately held companies are statistical evaluations.


Akebia Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Akebia Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Akebia Therapeutics is classified as operating in the Physical, Occupational & Speech Therapists & Audiologists industry, NAICS Code 62134.

Akebia Therapeutics Annual Revenue and Growth Rate

Akebia Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Akebia Therapeutics's revenues are gauged from an analysis of company filings.

Akebia Therapeutics's Income Statement (based on Industry Averages)

Akebia Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Akebia Therapeutics is developing and marketing. Akebia Therapeutics doesn't have any recent trademark applications, indicating Akebia Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ORCQESRO Pharmaceutical products and preparations for the treatment of anemia; pharmaceuticals for the treatment of anemia	06/07/2018
VAFSEO pharmaceutical products and preparations for the treatment of anemia; pharmaceuticals for the treatment of anemia	06/07/2018

See all trademarks and details in the Full Report.

Market Share of Akebia Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Akebia Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
ATHLETICO	Oak Brook, IL	100
SELECT REHABILITATION	Glenview, IL	88
REHAB EMPLOYEE SERVICES	Birmingham, AL	64
RELIANT PRO REHAB	Plano, TX	60
UPSTREAM NEWCO	Birmingham, AL	42
INHOME THERAPY	King Of Prussia, PA	42
ATI HOLDINGS	Bolingbrook, IL	41
IVYREHAB PT OT & SPEECH PLLC	White Plains, NY	40
U.S. PHYSICAL THERAPY	Houston, TX	32

Nearby Competitors

These companies are similar in business line and location to Akebia Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
STEPPING STONES HEALTHCARE SERVICES	Boston, MA	100
IORA HEALTH	Boston, MA	9
BAY STATE PHYSICAL THERAPY OF RANDOLPH	Braintree, MA	9
EYE HEALTH SERVICES	Weymouth, MA	1
AKEBIA THERAPEUTICS	Cambridge, MA	1
ELLIOTT PHYSICAL THERAPY	Milton, MA	1

Future Competition: Akebia Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Akebia Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)